A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma.
Rougier
P
P
Institut Gustave Roussy, Villeiuif, France.
Ducreux
M
M
Kerr
D
D
Carr
B I
BI
François
E
E
Adenis
A
A
Seymour
L
L
D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*
D000964:Antimetabolites, Antineoplastic; D005493:Folic Acid Antagonists; D011799:Quinazolines; D013876:Thiophenes; C068874:raltitrexed